EU Commission writes to CMC in response to industry concerns over device labelling decision
This article was originally published in Clinica
Executive Summary
The European Commission's Directorate General for Health and Consumer Policy (DG Sanco) has written to the Central Management Committee regarding the latter's Decision No 3 on device labelling. This decision, issued last July (www.clinica.co.uk, 18 July 2011), requires the full postal address of manufacturers and authorised representatives to be placed on medical devices.